Capital Purchase of Genetic Screening Processor and Panthera Punch
The Cardiff and Vale University Health Board have a requirement to replace the current Newborn Screening Analysers used for CHT and CF screening. The current equipment is at the end of life, as well as nearing discontinuation. Replacement is required with the newer version, the Revvity Genetic Service Processor (GSP) to ensure continuity of service provision, In addition to replacing the GSP, there is also a need to replace the current Panther multi puncher that is also at the very end of its lifespan
Buyer
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
Value
£511,496
Published
3 Jun 2026
Closes
3 Jun 2026
Procurement details
Source
Find a Tender
Region
United Kingdom
Procurement method
Limited
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33100000
Medical equipments
38434000
Analysers
Lots
Lot 1 Capital Purchase of Genetic Screening Processor and Panthera Punch
£511,496
Funding was approved to replace equipment within the Newborn Screening department that is nearing the end of lifespan. The replacement kit will allow continuity of service with no clinical risk impact. The equipment will be provided with a 12 month warranty. Additional information: The contract has been awarded on a direct award basis against the NHS Supply...
Delivery: Cardiff and Vale of Glamorgan
Documents
No document metadata is available for this public record.
Contains public sector information licensed under the Open Government Licence v3.0.